Guardant Health
GH
#3559
Rank
HK$24.06 B
Marketcap
HK$195.58
Share price
-1.18%
Change (1 day)
-8.80%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

P/S ratio for Guardant Health (GH)

P/S ratio as of September 2024 (TTM): 4.78

According to Guardant Health 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 4.78093. At the end of 2024 the company had a P/S ratio of 5.49.

P/S ratio history for Guardant Health from 2018 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20245.49-5.72%
20235.82-6.07%
20226.20-77.22%
202127.2-39.44%
202044.931.28%
201934.2-3.75%
201835.6

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
11.4 139.08%๐Ÿ‡บ๐Ÿ‡ธ USA
4.08-14.67%๐Ÿ‡บ๐Ÿ‡ธ USA